Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1970 1
1971 1
1972 1
1974 4
1977 1
1978 1
1979 3
1980 3
1981 3
1982 1
1983 2
1984 5
1985 3
1987 1
1988 6
1989 9
1990 4
1991 7
1992 9
1993 7
1994 13
1995 17
1996 28
1997 17
1998 21
1999 18
2000 15
2001 19
2002 24
2003 25
2004 30
2005 32
2006 60
2007 71
2008 56
2009 78
2010 95
2011 122
2012 136
2013 169
2014 200
2015 186
2016 175
2017 171
2018 188
2019 252
2020 316
2021 314
2022 365
2023 365
2024 433
2025 507
2026 78

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,217 results

Results by year

Filters applied: . Clear all
Page 1
Microbiota-driven antitumour immunity mediated by dendritic cell migration.
Lin NY, Fukuoka S, Koyama S, Motooka D, Tourlousse DM, Shigeno Y, Matsumoto Y, Yamano H, Murotomi K, Tamaki H, Irie T, Sugiyama E, Kumagai S, Itahashi K, Tanegashima T, Fujimaki K, Ito S, Shindo M, Tsuji T, Wake H, Watanabe K, Maeda Y, Enokida T, Tahara M, Yamashita R, Fujisawa T, Nomura M, Kawazoe A, Goto K, Doi T, Shitara K, Mano H, Sekiguchi Y, Nakamura S, Benno Y, Nishikawa H. Lin NY, et al. Nature. 2025 Aug;644(8078):1058-1068. doi: 10.1038/s41586-025-09249-8. Epub 2025 Jul 14. Nature. 2025. PMID: 40659786 Free PMC article.
KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy.
Guo J, Li N, Liu Q, Hao Z, Zhu G, Wang X, Wang H, Pan Q, Xu B, Han Y, Zhang G, Lian Y, Zhang W, Gu Y, Lin N, Zeng X, Jin Z, Lan W, Jiang J, Gao D, Dong L, Yuan H, Liang C, Qin J. Guo J, et al. Among authors: lin n. Cancer Cell. 2025 Jul 14;43(7):1261-1278.e10. doi: 10.1016/j.ccell.2025.04.002. Epub 2025 Apr 24. Cancer Cell. 2025. PMID: 40280125
Musculoskeletal Diseases: Mechanisms and Therapeutic Advances.
Ma X, Yinwang E, Chai X, Wang F, Chen Z, Wang S, Zhou H, Xue Y, Lei J, Chen F, Li H, Chen S, Zhao S, Wang K, Chen L, Gao J, Ye Z, Lin N. Ma X, et al. Among authors: lin n. MedComm (2020). 2025 Dec 4;6(12):e70519. doi: 10.1002/mco2.70519. eCollection 2025 Dec. MedComm (2020). 2025. PMID: 41357670 Free PMC article. Review.
Body-wide multi-omic counteraction of aging with GLP-1R agonism.
Huang J, Kwok AJ, Li JCY, Chiu CLH, Ip BY, Tung LY, Chan RCH, Chan DCW, Wang Z, Zheng X, Chow HT, Lo MPS, Li Z, Lin N, Wang M, Yan LYC, Wu WKK, Chow KH, Lin WJ, Tang Y, Zhang Y, Song W, Ng BW, Wong SH, Leung TW, Mok VCT, Ko H. Huang J, et al. Among authors: lin n. Cell Metab. 2025 Dec 2;37(12):2362-2380.e8. doi: 10.1016/j.cmet.2025.10.014. Epub 2025 Nov 19. Cell Metab. 2025. PMID: 41265449 Free article.
4,217 results